Skip to content

Extended hemodynamical monitoring using an esophageal doppler probe during thoracic surgery with lung tissue resection to reduce postoperative pulmonary complications

Extended hemodynamical monitoring using an esophageal doppler probe during thoracic surgery with lung tissue resection to reduce postoperative pulmonary complications - Esophageal doppler probe

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00006961
Enrollment
90
Registered
2015-02-02
Start date
2015-02-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34 J84

Interventions

Group 1: Patients of the control group undergoing thoracic surgery with lung tissue resection will receive the doppler probe after randomization. Resulting data will be recorded but not shown to the a

Sponsors

Anästhesiologische Universitätsklinik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients > 18 years of age - informed written consent - Operation in general anesthesia, endotracheal intubation and ventilation - lung resection using one-lung-ventilation

Exclusion criteria

Exclusion criteria: - denial of participation - severe heart failure - emergency surgery -body mass index > 50 - pacemaker or cardioverter - cardiac valve disease - history of pulmonary embolism - pathologies of esophagus or stomach - pregnancy - expected intraoperative blood loss of more than 1500 ml - drug history using diuretics - transfusion of blood or related products

Design outcomes

Primary

MeasureTime frame
Recording and analysis of postoperative pulmonary complications (a) after 24 h using spirometry, blood gas analysis and analysis of serum parameter (b) after 72 h using spirometry, blood gas analysis and analysis of serum parameter

Secondary

MeasureTime frame
Recording and analysis of postoperative renal complications and cytokine state (a) after 24 h using analysis of serum parameter (b) after 72 h using analysis of serum parameter

Countries

Germany

Contacts

Public ContactUlrich Göbel

Anästhesiologische Universitätsklinik

ulrich.goebel@uniklinik-freiburg.de0761 270 23340

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026